| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.027 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |